Is Semaglutide Covered by Insurance? What to Know in 2026

Introduction

The cost of semaglutide without insurance can exceed $1,000 per month, making insurance coverage a critical factor in treatment accessibility. Understanding semaglutide insurance coverage options can save you thousands of dollars and help you access this life-changing medication.

This guide explains how different insurance types cover semaglutide, what prior authorization requires, and practical strategies for improving your approval chances.

Does Insurance Cover Semaglutide?

Insurance coverage for semaglutide varies significantly by plan type, diagnosis, and carrier. Approximately 60-80% of commercial insurance plans cover semaglutide for type 2 diabetes, while coverage for weight loss indications is less consistent.

The distinction between FDA-approved indications matters enormously. Semaglutide is approved under the brand name Ozempic for diabetes management and under the brand name Wegovy for chronic weight management. Coverage often tracks these specific indications.

Medicare Part D plans are required to cover semaglutide when prescribed for FDA-approved indications, though prior authorization may apply. Medicaid coverage varies by state, with some states explicitly covering weight loss medications and others excluding them entirely.

Medicare Coverage

Medicare Part D covers semaglutide when medically necessary for approved indications. As of 2023, Medicare is prohibited from covering medications solely for weight loss under the Inflation Reduction Act provisions. However, semaglutide prescribed for cardiovascular risk reduction or type 2 diabetes remains covered.

For diabetic patients, Medicare Part D typically covers Ozempic with tier 2 or tier 3 co-pays, which can reduce monthly costs to $25-$100 depending on the specific plan. The coverage requires a valid prescription and documented medical necessity.

Part B may cover semaglutide administered in a clinical setting for specific indications, though most patients use the self-injection pens covered under Part D. Medicare Advantage plans must provide at least the same coverage as Original Medicare but may offer additional benefits.

Medicaid Coverage

Medicaid coverage for semaglutide varies dramatically by state. Some states, including California and New York, have expanded Medicaid coverage to include GLP-1 medications for both diabetes and weight management. Other states maintain strict limitations or exclude weight loss indications entirely.

For patients with type 2 diabetes, most state Medicaid programs cover semaglutide, though prior authorization requirements can be extensive. Typical requirements include documented failure of first-line diabetes medications, A1C above certain thresholds, and physician attestation of medical necessity.

Weight management coverage under Medicaid remains the exception rather than the rule. Only about 20 states cover GLP-1 medications specifically for obesity treatment through Medicaid. Coverage in these states typically requires a BMI of 30 or higher, or 27 with at least one weight-related comorbidity.

Commercial Insurance

Commercial insurers cover semaglutide at varying rates depending on plan design and formulary placement. Major carriers including UnitedHealthcare, Aetna, Cigna, and Blue Cross Blue Shield typically cover semaglutide for diabetes management with prior authorization.

Formulary tiers determine patient costs, with most plans placing semaglutide on tier 2 or tier 3. This typically results in co-pays ranging from $30-$100 for a monthly supply, compared to $900-$1,200 without insurance coverage.

Weight loss coverage remains inconsistent across commercial plans. Many employers have added GLP-1 coverage to their health benefits in recent years, particularly for employees with obesity-related comorbidities. However, standalone individual plans often exclude weight loss medications entirely.

Step therapy requirements are common, meaning insurers may require you to try and fail cheaper alternatives like metformin before approving semaglutide. Documenting this history in advance can expedite your prior authorization.

Prior Authorization Requirements

Prior authorization is almost universally required for semaglutide coverage, regardless of insurance type. Understanding these requirements helps you prepare complete documentation that accelerates approval.

Most insurers require documented evidence of type 2 diabetes diagnosis, including A1C values, fasting glucose levels, or glucose tolerance test results. For weight loss indications, they typically require BMI documentation and evidence of weight-related health conditions.

Physician notes must clearly articulate medical necessity, explaining why semaglutide is appropriate for your specific situation. This includes failed attempts at lifestyle modification, previous medication trials, and the anticipated clinical benefits of treatment.

Many insurers require ongoing monitoring and reporting to maintain coverage, including periodic A1C checks, weight documentation, and attestation of continued medical necessity. Missing these reporting deadlines can result in coverage termination.

Tips for Getting Coverage

Start with Your Formulary

Before pursuing any authorization, obtain your insurance plan formulary and verify semaglutide coverage details. Check the specific tier, any quantity limits, and associated requirements. This prevents wasting effort on treatments your plan does not cover.

Build a Complete Medical History

Compile documentation of all previous weight loss attempts, including structured diet programs, exercise plans, and medications tried. Include physician notes documenting these efforts and their results. This evidence supports the medical necessity case for semaglutide.

Obtain Prior Authorization Materials in Advance

Request your insurer's specific prior authorization form and requirements before your appointment. Provide these materials to your healthcare provider, ensuring they include all necessary clinical documentation. Many authorization delays stem from incomplete paperwork.

Explore Patient Assistance Programs

Novo Nordisk, the manufacturer of semaglutide, offers patient assistance programs for eligible individuals. These programs can provide medication at reduced or no cost for patients meeting income requirements and lacking adequate insurance coverage.

Consider Generic and Alternative Options

If semaglutide coverage is denied or prohibitively expensive, discuss alternatives with your healthcare provider. Other GLP-1 medications like liraglutide or dulaglutide may have better coverage, or compounding pharmacies may offer more affordable options.

Frequently Asked Questions

Does Medicare cover semaglutide for weight loss?

Medicare does not cover semaglutide solely for weight loss due to federal restrictions. However, Medicare Part D covers semaglutide when prescribed for FDA-approved indications like type 2 diabetes or cardiovascular risk reduction. Patients with both diabetes and obesity can often achieve coverage for weight management through the diabetes indication.

How can I get my semaglutide prior authorization approved?

Prior authorization approval requires complete documentation of medical necessity, including diabetes diagnosis with A1C values, previous treatment failures, and physician attestation. Ensure your healthcare provider submits all required clinical notes, lab results, and supporting documentation. Following up with both your provider's office and insurer can prevent delays.

What if my insurance denies semaglutide coverage?

If coverage is denied, you can appeal the decision through your insurer's formal appeals process. Work with your healthcare provider to submit additional clinical documentation supporting medical necessity. If the internal appeal fails, external review options are available. Patient assistance programs from the manufacturer may also provide alternative access.

How much does semaglutide cost with insurance?

With insurance coverage, semaglutide typically costs $25-$100 per month depending on your plan's formulary tier and deductible status. Without insurance, costs range from $900-$1,200 per month for Ozempic or Wegovy. Medicare Part D beneficiaries often pay the lowest co-pays, while commercial insurance costs vary by plan design.

Does Medicaid cover Wegovy for weight loss?

Medicaid coverage for Wegovy varies significantly by state. Approximately 20 states provide Medicaid coverage for GLP-1 medications specifically for weight management, while others limit coverage to diabetes indications only. Contact your state Medicaid program or managed care organization to determine specific coverage policies in your state.